Fundraising FoxAblacon
Wheat Ridge, US · Founded 2015 · Delaware corporation · 2 known investors
Find your way into Ablacon
Sign up to see every warm intro you have to Ablacon
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ablacon team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Boston Scientific develops cardiac electrophysiology mapping and ablation systems used by physicians to treat atrial fibrillation and other arrhythmias, including high-density mapping, pulsed field ablation, and electrographic flow source identification. Its systems support procedures such as pulmonary vein isolation through real-time catheter visualization and advanced electrogram analysis.
Founders & leadership
Ablacon was founded in 2015 by Dr. Philip Haeusser.
Investors · 2
How we know: a partner's Signal profile · westerntech.com · Not right? Tell us
How we know: prnewswire.com · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$51.5M disclosed across 2 rounds · 2019–2020
▶$30MraisedDec 2020 · 3 investors · Other TechnologyRule 506(b)
- Peter RuppersbergDirector
- Peter RuppersbergExecutive Officer, Director
- Peter RuppersbergExecutive Officer, Director
- Peter RuppersbergExecutive Officer, Director
- Offering amount
- $30M
- Amount sold
- $30M
- Minimum investment
- $375K
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$21.5MraisedMay 2019 · 2 investors · BiotechnologyRule 506(b)
- Peter RuppersbergExecutive Officer, Director
- Offering amount
- $21.5M
- Amount sold
- $21.5M
- Minimum investment
- $1.5M
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Ablacon do?
- Boston Scientific develops cardiac electrophysiology mapping and ablation systems used by physicians to treat atrial fibrillation and other arrhythmias, including high-density mapping, pulsed field ablation, and electrographic flow source identification. Its systems support procedures such as pulmonary vein isolation through real-time catheter visualization and advanced electrogram analysis.
- Who founded Ablacon?
- Ablacon was founded by Dr. Philip Haeusser in 2015.
- Who are Ablacon's investors?
- Ablacon's investors include Western Technology Investment, Ajax Health.
- How much funding has Ablacon raised?
- Ablacon has disclosed $51.5M raised across 2 rounds.
- Where is Ablacon headquartered?
- Ablacon is headquartered in Wheat Ridge, US.